Final rule 2026-20757
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/or the company that applied for the exemption no longer exists. These products will be removed from DEA's Table of Exempted Prescription Products and will no longer be considered exempt prescription products under the Controlled Substances Act. This action does not impact exempted prescription products with active NDC numbers.
Source-supplied record
Document details
- Document number
- 2026-20757
- Published
- Oct 9, 2026
- Effective
- Nov 9, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 64618
Docket identifiers
- Docket No. DEA-1664
CFR references
- Title 21, part 1308